{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:41:28Z","timestamp":1792698088581,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"DOI":"10.1007\/s13312-026-00433-1","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:39:34Z","timestamp":1792651174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BCG at 100: The Paradox of an Indispensable Vaccine"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1097-117X","authenticated-orcid":false,"given":"Vipin M.","family":"Vashishtha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"433_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","author":"BB Trunz","year":"2006","unstructured":"Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis. Lancet. 2006;367:1173\u201380.","journal-title":"Lancet"},{"key":"433_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2025.100599","volume":"14","author":"UB Singh","year":"2025","unstructured":"Singh UB, Rade K, Rao R, et al. Lessons and updates from India\u2019s National Tuberculosis Elimination Program. IJID Reg. 2025;14:100599.","journal-title":"IJID Reg"},{"key":"433_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13312-010-0013-6","volume":"47","author":"VM Vashishtha","year":"2010","unstructured":"Vashishtha VM, John TJ. Prevalence of Mycobacterium tuberculosis infection in children in western Uttar Pradesh. Indian Pediatr. 2010;47:97\u2013100.","journal-title":"Indian Pediatr"},{"key":"433_CR4","unstructured":"Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis Research Centre (ICMR), Chennai. Indian J Med Res. 1999;110:56-69."},{"key":"433_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S1473-3099(22)00222-5","volume":"22","author":"MF Cotton","year":"2022","unstructured":"Cotton MF, Madhi SA, Luabeya AK, et al. Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial. Lancet Infect Dis. 2022;22:1472\u201383.","journal-title":"Lancet Infect Dis"},{"key":"433_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","volume":"577","author":"PA Darrah","year":"2020","unstructured":"Darrah PA, Zeppa JJ, Maiello P, et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature. 2020;577:95\u2013102.","journal-title":"Nature"},{"key":"433_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","volume":"204","author":"P Aaby","year":"2011","unstructured":"Aaby P, Roth A, Ravn H, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis. 2011;204:245\u201352.","journal-title":"J Infect Dis"},{"key":"433_CR8","doi-asserted-by":"publisher","first-page":"e084745","DOI":"10.1136\/bmj-2025-084745","volume":"390","author":"B Adhisivam","year":"2025","unstructured":"Adhisivam B, Kamalarathnam C, Bhat BV, et al. Effect of BCG Danish and oral polio vaccine on neonatal mortality in newborn babies weighing less than 2000 g in India: multicentre open label randomised controlled trial (BLOW2). BMJ. 2025;390:e084745.","journal-title":"BMJ"},{"key":"433_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/14760584.2018.1483727","volume":"17","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann P, Curtis N. The influence of BCG on vaccine responses: a systematic review. Expert Rev Vaccines. 2018;17:547\u201354.","journal-title":"Expert Rev Vaccines"},{"key":"433_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s13312-015-0583-4","volume":"52","author":"MM Faridi","year":"2015","unstructured":"Faridi MM, Srivastava S. Effect of simultaneous administration of oral polio vaccine on local reaction of BCG vaccine in term infants. Indian Pediatr. 2015;52:115\u20138.","journal-title":"Indian Pediatr"},{"key":"433_CR11","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMoa2412381","volume":"392","author":"AC Schmidt","year":"2025","unstructured":"Schmidt AC, Fairlie L, Hellstrom E, et al. BCG revaccination for the prevention of Mycobacterium tuberculosis infection. N Engl J Med. 2025;392:1789\u20131800.","journal-title":"N Engl J Med"},{"key":"433_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105628","volume":"114","author":"M Tameris","year":"2025","unstructured":"Tameris M, Rozot V, Imbratta C, et al. Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial. EBioMedicine. 2025;114:105628.","journal-title":"EBioMedicine"},{"key":"433_CR13","doi-asserted-by":"publisher","first-page":"e085716","DOI":"10.1136\/bmj-2025-085716","volume":"393","author":"M Singh","year":"2026","unstructured":"Singh M, Joshi S, Vohra V, et al. Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial). BMJ. 2026;393:e085716.","journal-title":"BMJ"},{"key":"433_CR14","unstructured":"Central Drugs Standard Control Organisation. Special SEC (Vaccine)\u2014Minutes of Meeting 15. New Delhi: CDSCO; 2024. Accessed on August 2, 2026. Available from: https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Special%20SEC%20(Vaccine)%20-%20MOM15.pdf."},{"key":"433_CR15","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","volume":"379","author":"O Van Der Meeren","year":"2018","unstructured":"Van Der Meeren O, Hatherill M, Nduba V, et al. Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis. N Engl J Med. 2018;379:1621\u201334.","journal-title":"N Engl J Med"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-026-00433-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-026-00433-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-026-00433-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:01:56Z","timestamp":1792695716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-026-00433-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":15,"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1007\/s13312-026-00433-1","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Grammarly and QuillBot were used only for language editing and to improve readability. The author takes full responsibility for the accuracy, integrity, and originality of the manuscript.","order":2,"name":"Ethics","label":"Use of Artificial Intelligence (AI) Tools for Scientific Writing","group":{"name":"EthicsHeading","label":"Ethics"}}]}}